Concepts (60)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Metagenomics | 3 | 2022 | 109 | 1.540 |
Why?
|
| High-Throughput Nucleotide Sequencing | 3 | 2022 | 958 | 1.500 |
Why?
|
| Orf virus | 1 | 2025 | 4 | 0.950 |
Why?
|
| Ecthyma, Contagious | 1 | 2025 | 5 | 0.950 |
Why?
|
| Streptococcus pyogenes | 1 | 2025 | 79 | 0.890 |
Why?
|
| Soft Tissue Infections | 2 | 2025 | 91 | 0.890 |
Why?
|
| Streptococcal Infections | 1 | 2025 | 248 | 0.760 |
Why?
|
| Communicable Diseases | 1 | 2022 | 164 | 0.670 |
Why?
|
| Thyroiditis, Suppurative | 1 | 2019 | 5 | 0.650 |
Why?
|
| Thyroid Crisis | 1 | 2019 | 6 | 0.650 |
Why?
|
| Candida tropicalis | 1 | 2019 | 17 | 0.640 |
Why?
|
| Candidiasis | 1 | 2019 | 138 | 0.580 |
Why?
|
| Respiratory Syncytial Virus Infections | 1 | 2018 | 377 | 0.450 |
Why?
|
| Texas | 5 | 2025 | 3715 | 0.410 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2019 | 811 | 0.390 |
Why?
|
| Retrospective Studies | 6 | 2025 | 17518 | 0.280 |
Why?
|
| Adolescent | 7 | 2025 | 20601 | 0.260 |
Why?
|
| Sensitivity and Specificity | 2 | 2022 | 2171 | 0.250 |
Why?
|
| Goats | 1 | 2025 | 60 | 0.240 |
Why?
|
| Mycoplasma pneumoniae | 1 | 2025 | 13 | 0.230 |
Why?
|
| Pneumonia, Mycoplasma | 1 | 2025 | 14 | 0.230 |
Why?
|
| Child, Preschool | 6 | 2025 | 14838 | 0.230 |
Why?
|
| Infant | 5 | 2025 | 13201 | 0.230 |
Why?
|
| Sheep | 1 | 2025 | 237 | 0.230 |
Why?
|
| Typhoid Fever | 1 | 2024 | 19 | 0.220 |
Why?
|
| Salmonella typhi | 1 | 2024 | 21 | 0.220 |
Why?
|
| Severity of Illness Index | 2 | 2025 | 3104 | 0.210 |
Why?
|
| Plasma | 1 | 2022 | 105 | 0.190 |
Why?
|
| Skin | 1 | 2025 | 553 | 0.190 |
Why?
|
| Child | 5 | 2025 | 25843 | 0.170 |
Why?
|
| Immunocompromised Host | 1 | 2022 | 306 | 0.160 |
Why?
|
| Humans | 10 | 2025 | 134085 | 0.160 |
Why?
|
| Anti-Infective Agents | 1 | 2022 | 277 | 0.150 |
Why?
|
| Thyroidectomy | 1 | 2019 | 112 | 0.150 |
Why?
|
| Hospitals, Community | 1 | 2018 | 55 | 0.150 |
Why?
|
| Symptom Assessment | 1 | 2018 | 109 | 0.140 |
Why?
|
| Radiography, Thoracic | 1 | 2018 | 152 | 0.140 |
Why?
|
| Male | 7 | 2025 | 66057 | 0.140 |
Why?
|
| Hospitals | 1 | 2020 | 437 | 0.140 |
Why?
|
| Sepsis | 1 | 2022 | 519 | 0.130 |
Why?
|
| Incidence | 1 | 2025 | 3414 | 0.130 |
Why?
|
| Female | 6 | 2025 | 71851 | 0.110 |
Why?
|
| Length of Stay | 1 | 2018 | 1389 | 0.100 |
Why?
|
| Infant, Newborn | 1 | 2025 | 8607 | 0.090 |
Why?
|
| Clindamycin | 1 | 2011 | 42 | 0.090 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2011 | 198 | 0.080 |
Why?
|
| Staphylococcus aureus | 1 | 2011 | 480 | 0.070 |
Why?
|
| Anti-Bacterial Agents | 2 | 2024 | 2573 | 0.060 |
Why?
|
| Staphylococcal Infections | 1 | 2011 | 573 | 0.060 |
Why?
|
| Bacterial Proteins | 1 | 2011 | 934 | 0.060 |
Why?
|
| Genetic Variation | 1 | 2011 | 1619 | 0.050 |
Why?
|
| Treatment Outcome | 1 | 2019 | 13051 | 0.050 |
Why?
|
| Animals | 1 | 2025 | 36543 | 0.050 |
Why?
|
| Drug Resistance, Multiple, Bacterial | 1 | 2024 | 151 | 0.050 |
Why?
|
| Streptogramin A | 1 | 2011 | 1 | 0.020 |
Why?
|
| Erythromycin | 1 | 2011 | 21 | 0.020 |
Why?
|
| Staphylococcal Skin Infections | 1 | 2011 | 40 | 0.020 |
Why?
|
| Plasmids | 1 | 2011 | 529 | 0.020 |
Why?
|
| Drug Resistance, Bacterial | 1 | 2011 | 384 | 0.020 |
Why?
|
| Microbial Sensitivity Tests | 1 | 2011 | 834 | 0.020 |
Why?
|